Dimensional Fund Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-994,916
| Closed | -$9.35M | – | 3386 |
|
|
2020
Q3 | $9.35M | Sell |
994,916
-16,757
| -2% | -$159K | ﹤0.01% | 2225 |
|
|
2020
Q2 | $7.74M | Buy |
1,011,673
+35,816
| +4% | +$274K | ﹤0.01% | 2300 |
|
|
2020
Q1 | $6.03M | Buy |
975,857
+59,574
| +7% | +$525K | ﹤0.01% | 2335 |
|
|
2019
Q4 | $11.2M | Sell |
916,283
-178,409
| -16% | -$1.95M | ﹤0.01% | 2309 |
|
|
2019
Q3 | $12.6M | Sell |
1,094,692
-2,503
| -0.2% | -$26.3K | ﹤0.01% | 2246 |
|
|
2019
Q2 | $11M | Sell |
1,097,195
-766
| -0.1% | -$8.26K | ﹤0.01% | 2363 |
|
|
2019
Q1 | $14.1M | Sell |
1,097,961
-33
| -0% | -$491 | 0.01% | 2240 |
|
|
2018
Q4 | $16.7M | Sell |
1,097,994
-591
| -0.1% | -$11.3K | 0.01% | 2082 |
|
|
2018
Q3 | $22M | Sell |
1,098,585
-17,146
| -2% | -$390K | 0.01% | 2063 |
|
|
2018
Q2 | $21.8M | Sell |
1,115,731
-26,564
| -2% | -$588K | 0.01% | 2065 |
|
|
2018
Q1 | $23M | Sell |
1,142,295
-8,787
| -0.8% | -$149K | 0.01% | 1983 |
|
|
2017
Q4 | $15.3M | Sell |
1,151,082
-144
| -0% | -$2.17K | 0.01% | 2199 |
|
|
2017
Q3 | $21.2M | Sell |
1,151,226
-64,023
| -5% | -$1.19M | 0.01% | 2015 |
|
|
2017
Q2 | $22.4M | Buy |
1,215,249
+189,576
| +18% | +$3.76M | 0.01% | 1956 |
|
|
2017
Q1 | $23.1M | Buy |
1,025,673
+619,370
| +152% | +$14.8M | 0.01% | 1901 |
|
|
2016
Q4 | $14.1M | Buy |
406,303
+6,507
| +2% | +$194K | 0.01% | 2155 |
|
|
2016
Q3 | $9.8M | Buy |
399,796
+2,500
| +0.6% | +$62.5K | 0.01% | 2263 |
|
|
2016
Q2 | $9.5M | Hold |
397,296
| – | – | 0.01% | 2254 |
|
|
2016
Q1 | $9.3M | Sell |
397,296
-520
| -0.1% | -$12.3K | 0.01% | 2240 |
|
|
2015
Q4 | $12M | Buy |
397,816
+8,435
| +2% | +$273K | 0.01% | 2118 |
|
|
2015
Q3 | $15.5M | Sell |
389,381
-1,842
| -0.5% | -$114K | 0.01% | 1955 |
|
|
2015
Q2 | $27M | Sell |
391,223
-3,490
| -0.9% | -$220K | 0.02% | 1540 |
|
|
2015
Q1 | $21.6M | Sell |
394,713
-798
| -0.2% | -$38K | 0.01% | 1718 |
|
|
2014
Q4 | $16.9M | Hold |
395,511
| – | – | 0.01% | 1915 |
|
|
2014
Q3 | $12.6M | Buy |
395,511
+5,531
| +1% | +$118K | 0.01% | 2023 |
|
|
2014
Q2 | $8.08M | Buy |
389,980
+35,111
| +10% | +$649K | 0.01% | 2341 |
|
|
2014
Q1 | $6.87M | Buy |
354,869
+92
| +0% | +$1.95K | 0.01% | 2411 |
|
|
2013
Q4 | $8.61M | Sell |
354,777
-13,125
| -4% | -$309K | 0.01% | 2277 |
|
|
2013
Q3 | $7.9M | Buy |
367,902
+9,149
| +3% | +$216K | 0.01% | 2277 |
|
|
2013
Q2 | $7.98M | Buy |
+358,753
| New | +$7.91M | 0.01% | 2202 |
|
Dimensional Fund Advisors's AMAG Position: Q4 2020 in Review
Dimensional Fund Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 994,916 shares — an estimated $9.35M sold.
Dimensional Fund Advisors first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $27M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Dimensional Fund Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Dimensional Fund Advisors sold 994,916 AMAG Pharmaceuticals shares in Q4 2020, an estimated $9.35M.
- Dimensional Fund Advisors first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Dimensional Fund Advisors's AMAG Pharmaceuticals position peaked at $27M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Dimensional Fund Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.